A question I have is why the commercialisation of its product has not translated into any significant revenue?
If not mistaken, knee replacement is a fairly common surgery. If ATI and ACI have been approved in Australia, why have they not been adopted widely among the patients given its less-invasive and more sustainable treatments?
Cheers,
Tim
Potted Summary, page-2
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.0¢ |
Change
0.030(6.25%) |
Mkt cap ! $106.8M | |||
| Open | High | Low | Value | Volume |
| 50.5¢ | 53.0¢ | 50.0¢ | $1.171M | 2.284M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2918 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.5¢ | 40000 | 6 |
View Market Depth
| Last trade - 13.43pm 08/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |